keyword
https://read.qxmd.com/read/37818523/efficacy-of-dr-sks-hair-booster-serum-in-the-treatment-of-female-pattern-alopecia-in-patients-with-pcos-an-open-label-non-randomized-prospective-study
#1
JOURNAL ARTICLE
Stuti Khare
Background Many patients with polycystic ovary syndrome (PCOS) exhibit female pattern hair loss (FPHL). A more advanced, efficient, and suitable therapeutic approach is required to effectively manage FPHL in patients with PCOS. Aim Dr. SKS Hair Booster Serum is composed of copper, niacinamide, hyaluronic acid, thiamine, riboflavin, and biotin; each of these constituents has demonstrated individual efficacy in promoting hair growth and enhancing hair quality. We hereby assess the effectiveness of this novel hair formulation in treating FPHL in PCOS...
September 2023: Curēus
https://read.qxmd.com/read/37558233/systematic-review-of-mesotherapy-a-novel-avenue-for-the-treatment-of-hair-loss
#2
REVIEW
Aditya K Gupta, Shruthi Polla Ravi, Tong Wang, Mesbah Talukder, Michela Starace, Bianca Maria Piraccini
Mesotherapy is a technique by which lower doses of therapeutic agents and bioactive substances are administered by intradermal injections to the skin. Through intradermal injections, mesotherapy can increase the residence time of therapeutic agents in the affected area, thus allowing for the use of lower doses and longer intervals between sessions which may in turn improve the treatment outcome and patient compliance. This systematic review aims to summarize the current literature that evaluates the efficacy of this technique for the treatment of hair loss and provides an overview of the results observed...
December 2023: Journal of Dermatological Treatment
https://read.qxmd.com/read/37454698/pressure-alopecias-a-review
#3
REVIEW
Eduardo Corona-Rodarte, Luis Enrique Cano-Aguilar, Luisa Fernanda Baldassarri-Ortego, Antonella Tosti, Daniel Asz-Sigall
Pressure-induced alopecias (PAs) are an infrequent group of scarring and nonscarring alopecias that occur after ischemic obstruction of capillaries that leads to circumscribed areas of hair loss. Initially described after prolonged surgeries or immobilization, type 1 PA occurs after sustained external pressure to the skin, mainly the scalp prominences. Alopecia induced by cosmetic procedures, referred in this review as type 2 PA, is reported with increased frequency in literature and predominantly emerges from pressure exerted by the volume of injectables...
July 14, 2023: Journal of the American Academy of Dermatology
https://read.qxmd.com/read/37305191/mesotherapy-with-bicalutamide-a-new-treatment-for-androgenetic-alopecia
#4
Alba Gomez-Zubiaur, Juan Jose Andres-Lencina, Víctor Cabezas, Cristina Corredera, Fabio di Brisco, Blanca Ferrer, Ana Rodriguez-Villa, Daniela Subiabre-Ferrer, Cristian Valenzuela, David Vega Diez, Jose Maria Ricart
Bicalutamide is a selective androgen receptor antagonist. To date, it has been used orally with good efficacy results, but not in mesotherapy. In our center, we assessed whether patients undergoing bicalutamide mesotherapy showed positive responses and tolerated the local administration of bicalutamide. Six premenopausal women, with a mean age of 35.7 years and clinical diagnosis of Olsen Grade II or III female androgenetic alopecia accompanied by significant seborrhea were treated with 1 ml bicalutamide 0...
2023: International Journal of Trichology
https://read.qxmd.com/read/37265044/secondary-alopecia-induced-by-aesthetic-procedures-an-unrecognized-potential-complication
#5
REVIEW
Carlos A Barrera-Ochoa, María Teresa Alonso-León, Roberto Arenas, Maria Elisa Vega-Memjie, Daniel Asz-Sigall
Surgical facelifts and noninvasive techniques such as mesotherapy, hyaluronic fillers and botulinum toxin, among other procedures are widely used nowadays to reverse skin ageing and achieve rejuvenation effects. Secondary alopecia due to cosmetic procedures is a rare side effect and is poorly described in the literature. The mechanisms in which hair loss develops after an aesthetical procedure or surgical technique are not well known. The development of secondary scarring alopecia or non-scarring alopecia depends upon the interaction between different external factors, the individual host response and the extent of damage to the hair follicle anatomy...
August 2023: Australasian Journal of Dermatology
https://read.qxmd.com/read/37182050/the-efficacy-and-safety-of-dr-sks-hair-booster-serum-a-cocktail-of-micronutrients-and-multivitamins-in-adult-males-and-females-with-androgenetic-alopecia-an-open-label-non-randomized-prospective-study
#6
JOURNAL ARTICLE
Stuti Khare
Background Androgenetic alopecia (AGA) is frequently encountered in dermatological practice; however, there is a lack of approved treatment. At present, only three therapies have been approved for on-label use in androgenetic alopecia: minoxidil, finasteride, and lower-level laser therapy. Micronutrients are primary elements in the normal hair follicle cycle, and their role in androgenetic alopecia is a growing matter of research nowadays. This study aims to investigate the clinical efficacy and safety of Dr...
April 2023: Curēus
https://read.qxmd.com/read/36169916/what-s-new-in-therapy-for-male-androgenetic-alopecia
#7
JOURNAL ARTICLE
David Saceda-Corralo, Miguel Domínguez-Santas, Sergio Vañó-Galván, Ramon Grimalt
Male androgenetic alopecia is a common condition and represents a major concern for patients who experience this condition. While there are different treatments to stop hair loss and improve hair density, the 5-alpha reductase inhibitors have demonstrated to be effective in improving androgenetic alopecia in men and can maintain a positive response for many years. Oral finasteride 1 mg is a US FDA-approved option, but dutasteride 0.5 mg has been proven to induce better responses, especially in the frontal area...
January 2023: American Journal of Clinical Dermatology
https://read.qxmd.com/read/35851518/recent-modalities-in-treatment-of-telogen-effluvium-comparative-study
#8
RANDOMIZED CONTROLLED TRIAL
Fathia M Khattab, Areeg Rady, Shrook A Khashaba
Telogen effluvium is one of the most common forms of diffuse, non-scarring hair loss for which patients present for clinical evaluation. It is usually a reactive and reversible disorder. Identifying and correcting the underlying cause is the most important component in management, yet there is always a need for therapeutic options. This study aims to evaluate the efficacy of single session botulinum toxin A injection versus multiple sessions of multivitamins mesotherapy in the treatment of telogen effluvium...
October 2022: Dermatologic Therapy
https://read.qxmd.com/read/35816059/mesotherapy-with-dutasteride-for-androgenetic-alopecia-a-retrospective-study-in-real-clinical-practice
#9
JOURNAL ARTICLE
David Saceda-Corralo, Farah Moustafa, Óscar Moreno-Arrones, Pedro Jaén-Olasolo, Sergio Vañó-Galván, Francisco Camacho
BACKGROUND: 5-alpha inhibitors are an effective treatment for androgenetic alopecia. Mesotherapy with dutasteride has been proposed as an effective method to improve hair loss and reducing systemic absorption. OBJECTIVE: The main objective was to describe the safety profile of mesotherapy with dutasteride in real clinical practice in a large cohort of patients with androgenetic alopecia. A secondary aim was to describe the effectiveness of this treatment. METHODS AND MATERIALS: A multicentric retrospective study was designed...
July 1, 2022: Journal of Drugs in Dermatology: JDD
https://read.qxmd.com/read/35713007/minimally-invasive-procedures-for-the-management-of-female-pattern-hair-loss
#10
REVIEW
Daniel Fernandes Melo, Rita Fernanda Cortez de Almeida, Simone Carolina Frattini, Leopoldo Duailibe Nogueira Santos, Paulo Müller Ramos
BACKGROUND: Female Pattern Hair Loss (FPHL) is one of the most common types of hair loss in women. It is characterized by progressive follicular miniaturization leading to diffuse hair thinning over the midfrontal scalp with a negative impact on quality of life. Pharmacological treatments are commonly used, and hair follicle transplantation is an option for those cases with adequate donor area. Minimally invasive procedures, such as microneedling, mesotherapy, microinfusion of drugs into the scalp with tattoo machines (MMP®), and platelet-rich plasma (PRP) have been reported as adjuvant treatments...
November 2022: Journal of Cosmetic Dermatology
https://read.qxmd.com/read/35655649/truncal-anesthesia-for-hair-mesotherapy
#11
JOURNAL ARTICLE
Pablo Martín-Carrasco, Jose Bernabeu-Wittel, Mercedes Sendín-Martín, J J Domínguez-Cruz
No abstract text is available yet for this article.
January 2022: Journal of Cutaneous and Aesthetic Surgery
https://read.qxmd.com/read/35335987/advancing-regenerative-cellular-therapies-in-non-scarring-alopecia
#12
REVIEW
Talagavadi Channaiah Anudeep, Madhan Jeyaraman, Sathish Muthu, Ramya Lakshmi Rajendran, Prakash Gangadaran, Prabhu Chandra Mishra, Shilpa Sharma, Saurabh Kumar Jha, Byeong-Cheol Ahn
Alopecia or baldness is a common diagnosis in clinical practice. Alopecia can be scarring or non-scarring, diffuse or patchy. The most prevalent type of alopecia is non-scarring alopecia, with the majority of cases being androgenetic alopecia (AGA) or alopecia areata (AA). AGA is traditionally treated with minoxidil and finasteride, while AA is treated with immune modulators; however, both treatments have significant downsides. These drawbacks compel us to explore regenerative therapies that are relatively devoid of adverse effects...
March 10, 2022: Pharmaceutics
https://read.qxmd.com/read/35118130/two-cases-of-paradoxical-nonscarring-alopecia-after-mesotherapy-with-dutasteride
#13
Leandra Reguero Del Cura, Adrian De Quintana Sancho, Marta Rubio Lombraña, Ana Elisabet López Sundh, Marcos Antonio González López
Alopecia after mesotherapy with dutasteride is an extremely rare complication. Dutasteride is a second-generation 5a-reductase enzyme inhibitor that decreases serum dihydrotestosterone levels by 90%. It inhibits both type 1 and 2 enzymes, whereas finasteride inhibits only type 2. Mesotherapy with dutasteride is a novel treatment for hair fall which involves microinjection of the drug into the dermis with negligible systemic absorption. Frequent mild transitory side effects in the site of injection are described in medical literature, but few cases of secondary alopecia have been reported...
January 2022: Skin Appendage Disorders
https://read.qxmd.com/read/35100493/efficacy-of-botulinum-toxin-a-injection-in-the-treatment-of-androgenic-alopecia-a-comparative-controlled-study
#14
JOURNAL ARTICLE
Amany Nassar, Heba Abdel-Aleem, Mai Samir, Fathia M Khattab
INTRODUCTION: Scalp injection with mesotherapy (LC cell hair essence) helps in anchoring hair follicles and might have good therapeutic efficacy and lower side effects than Botox in the treatment of androgenetic alopecia (AGA). OBJECTIVE: To assess the trichoscopy and the clinical therapeutic response of LC hair essence serum injection vs. botulinum toxin (A) injection in the treatment of androgenetic alopecia. PATIENTS AND METHODS: Sixty-two AGA patients were included in the present study...
October 2022: Journal of Cosmetic Dermatology
https://read.qxmd.com/read/34877759/frontal-edema-due-to-mesotherapy-for-androgenetic-alopecia-a-case-series
#15
MULTICENTER STUDY
Daniel Fernandes Melo, David Saceda-Corralo, Antonella Tosti, Flavia Weffort, Machado Carla Jorge, Claudia Carreira de Barros, Raquel de Melo Carvalho, Michela Starace
Androgenetic alopecia (AGA) is the most common form of non-cicatricial alopecia in both genders. Currently approved drugs for the treatment of AGA include topical minoxidil in women and topical minoxidil and oral finasteride in men. Other routes of administration of approved drugs have been proposed to enhance therapeutic results for AGA, including intradermal injections, known as mesotherapy. Mesotherapy-or intradermotherapy-is a non-surgical procedure, consisting of multiple intradermal injections of pharmacological substances diluted in small doses...
February 2022: Dermatologic Therapy
https://read.qxmd.com/read/34305291/comparison-of-5-minoxidil-lotion-monotherapy-versus-its-combination-with-autologous-platelet-rich-plasma-in-androgenetic-alopecia-in-hundred-males
#16
JOURNAL ARTICLE
Rahul Ray, Aseem Sharma
BACKGROUND: Androgenetic alopecia (AGA) is the most common form of alopecia in men, affecting 70% by the age of 20 years. The present study was conducted with the objective of comparing the efficacy of monotherapy with topical 5% minoxidil and its combination with intradermal platelet rich plasma (PRP), in male AGA. METHODS: This observational study was conducted at the dermatology department of a tertiary care hospital over a duration of 2 years. 100 patients with AGA were selected and divided randomly into 2 treatment arms: Group A (MM): received topical 5% Minoxidil monotherapy for 12 months and; Group B (M + PRP): received combination therapy of PRP and topical 5% Minoxidil for 12 months...
July 2021: Medical Journal, Armed Forces India
https://read.qxmd.com/read/33557183/in-vitro-evaluation-of-the-effect-of-a-not-cross-linked-hyaluronic-acid-hydrogel-on-human-keratinocytes-for-mesotherapy
#17
JOURNAL ARTICLE
Nicola Zerbinati, Sabrina Sommatis, Cristina Maccario, Maria Chiara Capillo, Serena Di Francesco, Raffaele Rauso, Marina Protasoni, Edoardo D'Este, Daniela Dalla Gasperina, Roberto Mocchi
The multicomponent preparations for mesotherapy are based on the principle that skin and hair aging can be prevented by supplying the fundamental substrates for correct cellular functioning, such as nucleotides, vitamins, amino acids, and biomolecules including hyaluronic acid (HA) that promote skin hydration and several biological activities. The study provides evidence for the application of HYDRO DELUXE BIO (Matex Lab S.p.A), a biocompatible hydrogel containing not cross-linked HA, for the treatment of the scalp's skin by mesotherapy...
February 4, 2021: Gels
https://read.qxmd.com/read/33313048/efficacy-of-intralesional-and-oral-dutasteride-in-the-treatment-of-androgenetic-alopecia-a-systematic-review
#18
REVIEW
Maira Elizabeth Herz-Ruelas, Neri Alejandro Álvarez-Villalobos, Juan Manuel Millán-Alanís, Humberto de León-Gutiérrez, Sonia Sofía Ocampo-Garza, Minerva Gómez-Flores, Ramón Grimalt
Androgenetic alopecia is the most common cause of hair loss [ Br J Dermatol . 2011 Jan;164(1):5-15]. Finasteride and minoxidil are the only approved treatments [ J Am Acad Dermatol . 2008 Oct;59(4):547-8 and J Eur Acad Dermatology Venereol . 2018 Jan;32(1):11-22]. Dutasteride is more potent than finasteride due to its ability to inhibit both 5-α-reductase type I and II [ Our Dermatol Online . 2017 Sep;9(1):75-9] though its adverse effects and long half-life contribute to the reluctance on its oral use...
November 2020: Skin Appendage Disorders
https://read.qxmd.com/read/33269529/intradermal-injections-with-0-5-minoxidil-for-the-treatment-of-female-androgenetic-alopecia-a-randomized-placebo-controlled-trial
#19
RANDOMIZED CONTROLLED TRIAL
Barbara Pontes Cerqueira Uzel, Gustavo Henrique Soares Takano, Juliana Cabral Nunes Chartuni, Mariana Vicente Cesetti, Camila Fátima Biancardi Gavioli, André Moreira Lemes, Izelda Maria Carvalho Costa
Female androgenetic alopecia is one cause of alopecia in women, although the ideal treatment for this condition remains far from defined. The objective of this study was to evaluate the efficacy and safety of intradermal injections with 0.5% minoxidil for the management of female androgenetic alopecia in a randomized, placebo-controlled trial. A total of 54 women diagnosed with female androgenetic alopecia were divided into two groups: one group received intradermal injections of 0.5% minoxidil, and the other received 0...
January 2021: Dermatologic Therapy
https://read.qxmd.com/read/32827194/mesococktails-and-mesoproducts-in-aesthetic-dermatology
#20
REVIEW
Rajat Kandhari, Ishmeet Kaur, Divya Sharma
Mesotherapy is a convenient, safe and relatively painless non-surgical procedure. It has found its way into the aesthetic world and is employed for various indications such as lipolysis, skin rejuvenation, pigmentation and hair loss. The procedure involves delivery of mixture or cocktail of different compounds (plant extracts, nutrients, enzymes, homeopathic agents, pharmaceuticals, vitamins, amino acids and other bioactive substances) into the dermis or subcutaneous layer. A variety of techniques have been employed...
November 2020: Dermatologic Therapy
keyword
keyword
161348
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.